EditForce Breaks Ground with Promising Myotonic Dystrophy Type 1 Treatment Results EditForce, Inc. announces groundbreaking research showing long-term treatment efficacy for myotonic dystrophy type 1, demonstrating innovative technology and hope for patients.

EditForce Breaks Ground with Promising Myotonic Dystrophy Type 1 Treatment Results #Japan #Fukuoka #EditForce #MyotonicDystrophy #PPRTechnology